BRIO is Bordeaux’s integrated cancer research site (SIRIC).
It connects multidisciplinary research teams on the same site, working in synergy to produce new knowledge in oncology and fast-track its transfer for the benefit of patients.
BRIO is one of eight sites accredited by the French National Cancer Institute (INCa) for 2018-2022. This second accreditation was awarded to BRIO, among other things, for its innovative research programme selection process. Twenty-seven international experts were designated by BRIO and submitted with 9 multidisciplinary research programmes (designed by Bordeaux researchers). Following that process, three programmes were selected:
Through those programmes, BRIO calls on the skills of researchers in a wide range of fields involved in the fight against cancer :
biology, epidemiology, clinical medicine, sociology, physical sciences, chemistry, psychology, computer science, philosophy, mathematics, etc.
A strong patient involvement
Beyond the three research programmes, BRIO wishes to give a more important place to patients in the research environment, convinced that this collaboration can lead to better overall cancer care.
In 2016, a collective, ASPERON & Co (Associations and patients committed to research in oncology & professional community) was initiated to start connecting patients and scientists. Since then, the collective has co-constructed projects and events around themes chosen by the community.